Cargando…
Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor
The inhibition of dipeptidyl peptidase-IV (DPPIV) is a popular route for the treatment of type-2 diabetes. Commercially available gliptin-based drugs such as sitagliptin, anagliptin, linagliptin, saxagliptin, and alogliptin were specifically developed as DPPIV inhibitors for diabetic patients. The u...
Autores principales: | Rozano, Lina, Abdullah Zawawi, Muhammad Redha, Ahmad, Muhamad Aizuddin, Jaganath, Indu Bala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591938/ https://www.ncbi.nlm.nih.gov/pubmed/28932239 http://dx.doi.org/10.1155/2017/5124165 |
Ejemplares similares
-
Antioxidant Potential in Different Parts and Callus of Gynura procumbens and Different Parts of Gynura bicolor
por: Krishnan, Vijendren, et al.
Publicado: (2015) -
Antioxidant Capacity, Cytotoxicity, and Acute Oral Toxicity of Gynura bicolor
por: Teoh, Wuen Yew, et al.
Publicado: (2013) -
Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018) -
Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020) -
Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)